Lexogen

Lexogen is a Vienna-based provider of specialized RNA sequencing solutions and NGS services, operating at the intersection of the genomics and diagnostics sectors. The company has built a business model combining the sale of proprietary consumable kits (its technology platform) with a comprehensive fee-for-service operation, catering to a global customer base from its dual hubs in Austria and the United States. Recent high-profile partnerships, such as with Ochre Bio, demonstrate its capability to execute large-scale, complex sequencing projects, positioning it as a key enabler in the growing functional genomics and precision medicine markets. As a private company, it appears to be in a revenue-generating stage, supported by a strong technical support team and a focus on customer-centric innovation.

Proprietary library preparation kits for next-generation sequencing (NGS), with a specialized focus on RNA-Seq. The technology emphasizes reduced bias, compatibility with challenging samples (e.g., FFPE), and includes features like spike-in controls for data normalization and reproducibility.

Lexogen competes in a crowded field dominated by giants like Illumina (kits and services) and numerous other specialized kit vendors (e.g., New England Biolabs, Takara Bio) and contract research organizations (CROs) offering sequencing services. Its differentiation hinges on its specialized focus on RNA-Seq, the performance of its proprietary kits, and its reputation for high-touch technical support and collaborative project execution.